- Home
- TNGX vs MIR Comparison
TNGX vs MIR Comparison
Compare TNGX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MIR
- Stock Information
- Founded
- TNGX 2014
- MIR 2005
- Country
- TNGX United States
- MIR United States
- Employees
- TNGX N/A
- MIR N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MIR Industrial Machinery/Components
- Sector
- TNGX Health Care
- MIR Technology
- Exchange
- TNGX Nasdaq
- MIR Nasdaq
- Market Cap
- TNGX 351.2M
- MIR 5.0B
- IPO Year
- TNGX N/A
- MIR N/A
- Fundamental
- Price
- TNGX $5.63
- MIR $20.71
- Analyst Decision
- TNGX Strong Buy
- MIR Strong Buy
- Analyst Count
- TNGX 6
- MIR 4
- Target Price
- TNGX $12.20
- MIR $18.75
- AVG Volume (30 Days)
- TNGX 3.4M
- MIR 3.8M
- Earning Date
- TNGX 08-06-2025
- MIR 07-31-2025
- Dividend Yield
- TNGX N/A
- MIR N/A
- EPS Growth
- TNGX N/A
- MIR N/A
- EPS
- TNGX N/A
- MIR N/A
- Revenue
- TNGX $40,990,000.00
- MIR $870,200,000.00
- Revenue This Year
- TNGX N/A
- MIR $6.45
- Revenue Next Year
- TNGX N/A
- MIR $7.51
- P/E Ratio
- TNGX N/A
- MIR N/A
- Revenue Growth
- TNGX 10.09
- MIR 7.25
- 52 Week Low
- TNGX $1.03
- MIR $9.11
- 52 Week High
- TNGX $12.02
- MIR $22.21
- Technical
- Relative Strength Index (RSI)
- TNGX 77.32
- MIR 57.76
- Support Level
- TNGX $4.80
- MIR $20.21
- Resistance Level
- TNGX $5.63
- MIR $22.21
- Average True Range (ATR)
- TNGX 0.52
- MIR 0.73
- MACD
- TNGX -0.03
- MIR -0.12
- Stochastic Oscillator
- TNGX 83.33
- MIR 47.55
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.